Clearpoint Neuro, Inc. revenue
Clearpoint Neuro, Inc.'s revenue was $37.0m in fiscal 2025, up 17.8% on the year before. Since fiscal 2010 ($2.7m) it has grown at a compound 19.2% a year. Over the last twelve months it was $45.5m.
Revenue history
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 4 | 5 | 4 | 4 | 5 | 6 | 7 | 7 | 11 | 13 | 16 | 21 | 24 | 31 | 37 | 45 |
| Growth on the year before | — | +43.0% | +32.5% | −22.3% | −8.3% | +27.5% | +25.1% | +28.4% | −0.4% | +52.5% | +14.4% | +27.0% | +26.1% | +16.6% | +31.0% | +17.8% | — |
| Gross profit | — | — | — | — | — | — | — | 4 | 5 | 7 | 9 | 11 | 14 | 14 | 19 | 23 | 28 |
Where the revenue comes from
| Line of business | Revenue | YoY |
|---|---|---|
| Products | $23.9M | ▲ 28.1% |
| Biologics and Drug Delivery | $19M | ▲ 10.0% |
| Neurosurgery Navigation and Therapy Disposable Products | $14.8M | ▲ 44.2% |
| Neurosurgery Navigation and Therapy | $14.8M | ▲ 44.2% |
| Services | $13.1M | ▲ 2.7% |
| Biologics and Drug Delivery Services and License Fees | $11.7M | 0.0% |
| Biologics and Drug Delivery Disposable Products | $7.3M | ▲ 30.9% |
| Capital Equipment and Software | $3.1M | ▼ 18.3% |
| Capital Equipment and Software Related Service | $2.1M | ▼ 8.7% |
| Capital Equipment and Software Systems and Software Products | $1.7M | ▼ 38.2% |
| Capital Equipment and Software Services | $1.4M | ▲ 33.0% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Clearpoint Neuro, Inc.'s 10-K filed March 17, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Clearpoint Neuro, Inc. | $45.5m | 32.5% | 26.8% |
| Koru Medical Systems, Inc. | $45.1m | 22.4% | 15.3% |
| Trisalus Life Sciences, Inc. | $45.1m | 25.2% | 45.1% |
| Sanuwave Health, Inc. | $44.0m | 12.7% | 34.4% |
| Myomo, Inc. | $43.3m | 6.1% | 35.4% |
| Senseonics Holdings, Inc. | $48.5m | 90.6% | 38.0% |
Compare with peers
- Koru Medical Systems, Inc. revenue
- Trisalus Life Sciences, Inc. revenue
- Sanuwave Health, Inc. revenue
- Myomo, Inc. revenue
- Senseonics Holdings, Inc. revenue
Head to head: CLPT vs KRMDCLPT vs TLSICLPT vs SNWVCLPT vs SENS
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies